Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate (Q46611130)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2005

edit

Language	Label	Description	Also known as
English	Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate	scientific article published in September 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

title

Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

main subject

leukemia

1 reference

based on heuristic

inferred from title

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

author

Alex Thompson

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

author name string

McMullin MF

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

Nugent E

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

Hull D

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

Jones FG

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

Grimwade D

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

publication date

1 September 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

published in

Leukemia

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

volume

19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

page(s)

1676-1677

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

cites work

The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403883

retrieved

21 January 2018

Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403883

retrieved

21 January 2018

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403883

retrieved

21 January 2018

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403883

retrieved

21 January 2018

Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in v

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403883

retrieved

21 January 2018

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403883

retrieved

21 January 2018

Identifiers

DOI

10.1038/SJ.LEU.2403883

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

PubMed publication ID

16034463

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16034463

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/16034463

ResearchGate publication ID

7711721

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46611130&oldid=2207978450"